Andrew Guggenhime's Net Worth
$22.6 Million
Who is Andrew Guggenhime?
Andrew Guggenhime has an estimated net worth of $22.6 Million. This is based on reported shares across multiple companies, which include Vaxcyte, Inc., NEOFORMA INC, FACET BIOTECH CORP, Caribou Biosciences, Inc., Dermira, Inc., Metacrine, Inc., and PDL BIOPHARMA, INC..
SEC CIK
Andrew Guggenhime's CIK is 0001230724
Past Insider Trading and Trends
2022 was Andrew Guggenhime's most active year for acquiring shares with 16 total transactions. Andrew Guggenhime's most active month to acquire stocks was the month of July. 2024 was Andrew Guggenhime's most active year for disposing of shares, totalling 31 transactions. Andrew Guggenhime's most active month to dispose stocks was the month of July. 2017 saw Andrew Guggenhime paying a total of $2,411,100.00 for 87,875 shares, this is the most they've acquired in one year. In 2010 Andrew Guggenhime cashed out on 176,729 shares for a total of $4,771,652.68, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Vaxcyte, Inc. (PCVX) Snapshot price: $111.58
PRESIDENT AND CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 7
| |||
Form 4
| +21.14% | 19.11K |
$20.93 | $399,930.44 | 109.49K |
Oct 25
| |||
Form 4
|
—
|
0
|
$60.37 | -$4,621,808.21 | 90.38K |
Scheduled
|
Oct 18
| ||
Form 4
| -6.55% | -6.34K |
$110.15 | -$698,020.55 | 90.38K |
Sep 3
| |||
Form 4
|
—
|
0
|
$41.97 | -$585,850.32 | 96.72K |
Scheduled
|
Aug 19
| ||
Form 4
|
—
|
0
|
$43.26 | -$606,525.13 | 96.72K |
Scheduled
|
Jul 18
| ||
Form 4
|
—
|
0
|
$38.64 | -$532,574.72 | 96.72K |
Scheduled
|
Jun 18
| ||
Form 4
|
—
|
0
|
$40.17 | -$557,109.18 | 95.68K |
Scheduled
|
May 20
| ||
Form 4
|
—
|
0
|
$33.31 | -$447,399.41 | 95.68K |
Scheduled
|
Apr 18
| ||
Form 4
|
—
|
0
|
$37.18 | -$509,343.75 | 95.68K |
Scheduled
|
Mar 18
| ||
Form 4
| +20.39% | 16.2K |
$71.55 | -$271,532.25 | 95.68K |
Feb 29 - Mar 2
| |||
Form 4
|
—
|
0
|
$39.94 | -$553,431.64 | 79.47K |
Scheduled
|
Feb 20
| ||
Form 4
|
—
|
0
|
$33.04 | -$443,078.63 | 79.47K |
Scheduled
|
Jan 18
| ||
Form 4
|
—
|
0
|
$32.77 | -$438,616.77 | 79.47K |
Scheduled
|
Dec 18
| ||
Form 4
|
—
|
0
|
$32.78 | -$768,180.00 | 79.47K |
Scheduled
|
Dec 14
| ||
Form 4
|
—
|
0
|
$28.24 | -$366,262.92 | 79.47K |
Scheduled
|
Nov 20
| ||
Form 4
|
—
|
0
|
$25.63 | -$324,500.31 | 79.47K |
Scheduled
|
Oct 18
| ||
Form 4
| -4.30% | -3.57K |
$51.00 | -$181,968.00 | 79.47K |
Sep 5
| |||
Form 4
| +33.93% | 20.77K |
$41.49 | -$71,653.23 | 82K |
Mar 1 - Mar 2
| |||
Form 4
| +63.11% | 23.69K |
$5.35 | $126,746.85 | 61.23K |
Dec 30
| |||
Form 4
|
—
|
0
|
$15.73 | -$64,312.88 | 37.54K |
Scheduled
|
Sep 19
| ||
Form 4
| -11.02% | -4.65K |
$26.38 | -$122,640.62 | 37.54K |
Sep 2
| |||
Form 4
|
—
|
0
|
$16.68 | -$815,400.00 | 42.19K |
Scheduled
|
Aug 25 - Aug 29
| ||
Form 4
|
—
|
0
|
$15.31 | -$61,735.24 | 42.19K |
Scheduled
|
Aug 18
| ||
Form 4
|
—
|
0
|
$14.94 | -$59,462.23 | 42.19K |
Scheduled
|
Jul 18
| ||
Form 4
|
—
|
0
|
$14.68 | -$57,815.00 | 42.19K |
Scheduled
|
Jul 8
| ||
Form 4
|
—
|
0
|
$14.90 | -$59,177.80 | 42.19K |
Scheduled
|
May 18
| ||
Form 4
|
—
|
0
|
$14.70 | -$57,957.29 | 40.63K |
Scheduled
|
Apr 18
| ||
Form 4
|
—
|
0
|
$15.74 | -$64,407.77 | 40.63K |
Scheduled
|
Mar 18
| ||
Form 4
| +1,200.00% | 37.5K |
—
|
—
| 40.63K |
Mar 2
| |||
Form 4
|
—
|
0
|
$14.68 | -$115,630.00 | 3.13K |
Scheduled
|
Mar 1
| ||
Form 4
|
—
|
0
|
$14.68 | -$57,815.00 | 3.13K |
Scheduled
|
Dec 23
| ||
Form 4
|
—
|
0
|
$14.94 | -$59,445.50 | 3.13K |
Scheduled
|
Nov 18
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NEOFORMA INC No price found
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +18.10% | 10K |
—
|
—
| 65.25K |
Mar 23
| |||
Form 4
| -0.91% | -500.00 |
$10.00 | -$5,000.00 | 54.48K |
Scheduled
|
Sep 13
| ||
Form 4
| -0.90% | -500.00 |
$10.00 | -$5,000.00 | 54.98K |
Scheduled
|
Aug 31
| ||
Form 4
| +2.54% | 1.37K |
$5.70 | $7,819.24 | 55.48K |
Jul 30
| |||
Form 4
| -0.92% | -500.00 |
$10.95 | -$5,475.00 | 54.1K |
Scheduled
|
Jul 12
| ||
Form 4
| -0.91% | -500.00 |
$11.95 | -$5,975.00 | 54.6K |
Scheduled
|
Jun 16
| ||
Form 4
| -0.90% | -500.00 |
$11.62 | -$5,810.00 | 55.1K |
Scheduled
|
Jun 9
| ||
Form 4
| -1.77% | -1.00K |
$12.35 | -$12,350.00 | 55.6K |
Scheduled
|
May 11
| ||
Form 4
| +58.54% | 20.9K |
—
|
—
| 56.6K |
Feb 20
| |||
Form 4
| +3.04% | 1.05K |
$5.70 | $5,996.84 | 35.7K |
Jan 30
| |||
Form 4
| +6.87% | 2.23K |
$5.70 | $12,677.07 | 34.65K |
Jul 31
| |||
| No matching records found | |||||||||
FACET BIOTECH CORP No price found
SVP & CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -32.09K |
$27.00 | -$866,430.00 |
0
|
Apr 21
| |||
Form 4
| -27.84% | -12.38K |
$27.00 | -$334,341.00 | 32.09K |
Apr 20
| |||
Form 4
| -3.30% | -1.52K |
$26.98 | -$40,901.68 | 44.47K |
Apr 3
| |||
Form 4
| +49.62% | 15.25K |
—
|
—
| 45.99K |
Aug 6
| |||
Form 4
| -4.59% | -1.48K |
$9.79 | -$14,469.62 | 30.74K |
Apr 2 - Apr 3
| |||
Form 4
| +1,131.50% | 29.6K |
—
|
—
| 32.22K |
Jan 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Caribou Biosciences, Inc. (CRBU) Snapshot price: $1.76
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Dermira, Inc. No price found
CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -41.95K |
$18.75 | -$786,581.25 |
0
|
Feb 20
| |||
Form 4
| +18.96% | 6.52K |
$7.91 | -$27,297.41 | 40.93K |
Aug 15
| |||
Form 4
| +90.62% | 16.36K |
$10.50 | -$90,772.50 | 34.4K |
May 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 12
| |||
Form 4
| +47.09% | 5.28K |
$9.58 | -$26,766.52 | 16.5K |
Aug 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 15
| |||
Form 4
| +41.69% | 2.96K |
$23.58 | -$42,113.88 | 10.07K |
Aug 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 17
| |||
Form 4
|
—
|
0
|
$20.27 | -$120,991.00 | 5.12K |
Scheduled
|
Nov 9
| ||
Form 4
|
—
|
0
|
$19.93 | -$314,213.65 | 5.12K |
Scheduled
|
Oct 11
| ||
Form 4
|
—
|
0
|
$20.26 | -$442,500.00 | 5.12K |
Scheduled
|
Sep 19
| ||
Form 4
|
—
|
0
|
$19.02 | -$270,200.00 | 5.12K |
Scheduled
|
Sep 12
| ||
Form 4
| +16.94% | 741 |
$31.59 | -$14,120.73 | 5.12K |
Aug 15
| |||
Form 4
|
—
|
0
|
$18.27 | -$255,074.00 | 4.38K |
Scheduled
|
Aug 11
| ||
Form 4
|
—
|
0
|
$17.83 | -$246,433.28 | 4.38K |
Scheduled
|
Jul 11
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||